drugset
drugset / Trial / NCT05512806

A Bioavailability and Food Effect Study of AZD5462 in Healthy Volunteers

NCT05512806 ↗

Phase 1 Completed 16 enrolled AstraZeneca Parexel · collab
RandomizedCrossoverOpen-labelTreatment

Summary

This study will assess the pharmacokinetics of AZD5462 film-coated tablet formulation in healthy participants.

Timeline

Start
2022-08-24
Primary completion
2022-11-07
Completion
2022-11-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD5462 Unknown — Oral

Indications

No indication recorded.